GPO Plus, Inc. (GPOX)

Revenue by Segment

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020	Apr 30, 2019	Apr 30, 2018	Apr 30, 2017	Apr 30, 2016
Wholesale - Drugs	4.74M	4.36M	653.52K	1.16M	826.73K
Wholesale - Drugs Growth	8.92%	566.59%	-43.80%	40.65%	-
Total	4.74M	4.36M	653.52K	1.16M	826.73K
Total Growth	8.92%	566.59%	-43.80%	40.65%	-

Revenue by Geography

Financials in millions USD. Fiscal year is May - April.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020	Apr 30, 2019	Apr 30, 2018	Apr 30, 2017	Apr 30, 2016
United States	4.74M	4.36M	653.52K	1.16M	826.73K
United States Growth	8.92%	566.59%	-43.80%	40.65%	-
Total	4.74M	4.36M	653.52K	1.16M	826.73K
Total Growth	8.92%	566.59%	-43.80%	40.65%	-

Data Source: S&P Global Market Intelligence Last updated: Jan 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 14, 2026

Data Sources Report a data error